GSK GlaxoSmithKline PLC ADR

USD 35.90 -1.12 ( -3.03)%
Icon

GlaxoSmithKline PLC ADR (GSK) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | NYE
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 35.90

-1.12 (-3.03)%

N/A

0.01B

USD 50.00(+39.28%)

USD 44.00 (+22.56%)

Icon

GSK

GlaxoSmithKline PLC ADR (USD)
COMMON STOCK | NYE
USD 35.90
-1.12 ( -3.03)%

GlaxoSmithKline PLC ADR (GSK) Stock Forecast

USD 50.00
(+39.28%)

Based on the GlaxoSmithKline PLC ADR stock forecast from 2 analysts, the average analyst target price for GlaxoSmithKline PLC ADR is USD 50.00 over the next 12 months. GlaxoSmithKline PLC ADR’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of GlaxoSmithKline PLC ADR is Slightly Bearish, which is based on 1 positive signals and 2 negative signals. At the last closing, GlaxoSmithKline PLC ADR’s stock price was USD 35.90. GlaxoSmithKline PLC ADR’s stock price has changed by -3.00% over the past week, -7.52% over the past month and +3.19% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...